Overview

The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This study will qualify a functional model that can measure central blood pressure and vascular compliance effects through noninvasive means.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Isosorbide
Isosorbide Dinitrate
Isosorbide-5-mononitrate
Losartan